Vous n'êtes pas identifié (connexion)

Centre de recherche

BOTTIN

Rodica Gilca

Formation
à venir

Aucune offre active

Autres opportunités de carrière
Axe principal
Maladies infectieuses et immunitaires
Adresse(s)
2400, avenue d'Estimauville
3e étage
Québec (Québec)
CANADA G1E 7G9

Téléphone(s)
+1 418-666-7000, poste 278
Télécopieur(s)
+1 418-666-2776
Courriel(s)
Rodica.Gilca@inspq.qc.ca

Projet(s) de recherche reconnu(s) par l'Université Laval

Autre(s) projet(s) de recherche actif(s)

Aucun projet de recherche à afficher

Publications récentes (voir toutes les publications de ce chercheur)

De Wals P, Deceuninck G, Lefebvre B, Tsang R, Law D, De Serres G, Gilca V, Gilca R, Boulianne N. Impact of an immunization campaign to control an increased incidence of Serogroup B meningococcal disease in one region of Quebec, Canada. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America,  2017. Epub
Longtin Y, Gilca R, Loo VG. Effect Of Detecting and Isolating Asymptomatic Clostridium difficile Carriers-Reply. JAMA internal medicine,  2016. 176: 1573
Jones CH, Mohamed N, Rojas E, Andrew L, Hoyos J, Hawkins JC, McNeil LK, Jiang Q, Mayer LW, Wang X, Gilca R, De Wals P, Pedneault L, Eiden J, Jansen KU, Anderson AS. Comparison of Phenotypic and Genotypic Approaches to Capsule Typing of Neisseria meningitidis by Use of Invasive and Carriage Isolate Collections. Journal of clinical microbiology,  2016. 54: 25-34
Longtin Y, Paquet-Bolduc B, Gilca R, Garenc C, Fortin E, Longtin J, Trottier S, Gervais P, Roussy JF, Levesque S, Ben-David D, Cloutier I, Loo VG. Effect of Detecting and Isolating Clostridium difficile Carriers at Hospital Admission on the Incidence of C difficile Infections: A Quasi-Experimental Controlled Study. JAMA internal medicine,  2016. Epub
Zhou Z, Gilca R, Deceuninck G, Boucher FD, Charest H, DE Wals P. Predictors of hospitalization for lower respiratory tract infection in children aged <2 years in the province of Quebec, Canada. Epidemiology and infection,  2016. 144: 1035-44
Skowronski DM, Chambers C, Gilca R, De Serres G. Repeat Influenza Vaccination and High-Dose Efficacy. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America,  2016. Epub
Kong LY, Dendukuri N, Schiller I, Bourgault AM, Brassard P, Poirier L, Lamothe F, Beliveau C, Michaud S, Turgeon N, Toye B, Frost EH, Gilca R, Dascal A, Loo VG. Predictors of asymptomatic Clostridium difficile colonization on hospital admission. American journal of infection control,  2015. 43: 248-53
Gilca R, Douville-Fradet M, Amini R, De Serres G, Boulianne N, Charest H, Dubuque J. Hospitalisations et complications attribuables à l'influenza : rapport de l'étude 2013-2014 [Montréal]: Institut national de santé publique du Québec, 2015. 19 + annexes pages.
Gilca R, Skowronski DM, Douville-Fradet M, Amini R, Boulianne N, Rouleau I, Martineau C, Charest H, De Serres G. Mid-Season Estimates of Influenza Vaccine Effectiveness against Influenza A(H3N2) Hospitalization in the Elderly in Quebec, Canada, January 2015. PLoS ONE,  2015. 10: e0132195
Law DK, Lefebvre B, Gilca R, Deng S, Zhou J, De Wals P, Tsang RS. Characterization of invasive Neisseria meningitidis strains from Quebec, Canada, during a period of increased serogroup B disease, 2009-2013: phenotyping and genotyping with special emphasis on the non-carbohydrate protein vaccine targets. BMC microbiology,  2015. 15: 143
© 2017 Tous droits réservés Centre de recherche du CHU de Québec